Most employers believe they have separate healthcare problems:

• An MSK problem
• An obesity problem
• A GLP-1 problem
• A pharmacy trend problem

They don’t.

They have a pathway problem.

In this episode, we connect the dots most benefit strategies keep siloed and make the case that musculoskeletal pain is often the front door to long-term metabolic dysfunction.

When something hurts, people move less.

When movement drops, insulin sensitivity declines.

When metabolism shifts, risk compounds.

Months or years later, that shows up in a completely different budget category.

By the time you’re debating GLP-1 spend, the pathway was already set.

GLP-1 didn’t create your metabolic risk.

It revealed it.

In This Episode: ...